The German insurer is placing a hefty bet on Southeast Asia’s wealth hub, combining a long-sought acquisition with a leaner leadership team. Allianz has agreed to buy HSBC Life Singapore for approximately S$2.9 billion (€2.0 billion), securing a 15-year exclusive distribution pact with the British banking giant in the city-state. The deal, expected to close in the first half of 2027 pending regulatory approval, marks a strategic reset after the collapse of a planned €1.15 billion takeover of Income Insurance in late 2024, which was blocked by political opposition in Singapore.
Allianz outbid Japanese rivals Daiichi Life and Sumitomo in the auction process, according to media reports. The acquisition comes with an upfront payment of S$200 million for the distribution rights, a structure designed to generate a double-digit return on invested capital over the medium term. HSBC Life Singapore posted an operating profit of €80 million in 2025 on equity of €1.2 billion. For HSBC, the sale is expected to yield a pre-tax gain of $1.8 billion and improve its core capital ratio by up to 15 basis points, as chief executive Georges Elhedery continues to streamline the bank’s portfolio toward core markets.
The timing of the expansion coincides with a significant shake-up at Allianz’s top table. Günther Thallinger, a board member since 2017 who oversaw capital investments, health insurance and sustainability, will leave the company at year-end. His responsibilities are being split: Andreas Wimmer will take charge of proprietary investments, while Tomas Kunzmann — already leading the health segment — adds Asia and sustainability to his remit. Klaus-Peter Röhler is also retiring, with Kunzmann stepping into his role from January 1, 2027. The net effect is a smaller board, a structure that analysts say aligns with the group’s sharper focus on Asia.
Should investors sell immediately? Or is it worth buying Allianz?
CEO Oliver Bäte has long described Singapore as the nerve center of Allianz’s Asian operations, noting that one in every four euros of insurance premium the group collects worldwide now comes from the region. The distribution agreement with HSBC gives Allianz privileged access to the bank’s affluent customer base in Singapore, a market where life insurance penetration is high and demand for wealth-management products is growing.
Investors have taken the twin announcements in stride. Allianz shares closed Friday at €425.30, just 1.23% below their 52-week high, and have gained 8.91% since the start of the year. The stock touched €426.50 during Friday’s session, edging back toward the €430.60 peak reached earlier in the week. Analyst price targets remain broadly clustered around €420, though some bullish forecasts stretch as high as €684.
The next major catalyst for the stock arrives on August 7, when Allianz releases its half-year results. The group is targeting full-year 2026 operating profit of €17.4 billion, and investors will be watching for management’s initial commentary on how quickly the Singapore acquisition — and the broader Asian push — can start showing up in the numbers.
Ad
Allianz Stock: Buy or Sell?! New Allianz Analysis from July 25 delivers the answer:
The latest Allianz figures speak for themselves: Urgent action needed for Allianz investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 25.
Allianz: Buy or sell? Read more here...
